dc.contributorTorre, A.V.D.L., Unitat de Farmacologia i Farmacognsia, Facultat de Farmcia, Nucli Universitari de Pedralbes, 08028 Barcelona, Spain; Junyent, F., Unitat de Farmacologia i Farmacognsia, Facultat de Farmcia, Nucli Universitari de Pedralbes, 08028 Barcelona, Spain, Unitat de Bioquimica, Facultat de Medicina i Cincies de la Salut, Universitat Rovira i Virgili, C./St. Lloren 21, 43201 Reus, Tarragona, Spain; Folch, J., Unitat de Bioquimica, Facultat de Medicina i Cincies de la Salut, Universitat Rovira i Virgili, C./St. Lloren 21, 43201 Reus, Tarragona, Spain; Pelegrí, C., Departament de Fisiologia, Centro de Investigación de Biomedicina en Red de Enfermedades Neurodegenerativas (CIBERNED), Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain; Vilaplana, J., Departament de Fisiologia, Centro de Investigación de Biomedicina en Red de Enfermedades Neurodegenerativas (CIBERNED), Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain; Auladell, C., Departament de Biologia Cellular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Beas-Zarate, C., Departamento de Biología Celular y Molecular, CUCBA, Col. Independencia, Sierra Mojada 800, Guadalajara, Jalisco 44340, Mexico; Palls, M., Unitat de Farmacologia i Farmacognsia, Facultat de Farmcia, Nucli Universitari de Pedralbes, 08028 Barcelona, Spain; Camins, A., Unitat de Farmacologia i Farmacognsia, Facultat de Farmcia, Nucli Universitari de Pedralbes, 08028 Barcelona, Spain; Verdaguer, E., Departament de Biologia Cellular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
dc.contributorBeas-Zárate, Carlos., Universidad de Guadalajara. Centro Universitario de Ciencias Biológicas y Agropecuarias
dc.creatorTorre, A.V.D.L.
dc.creatorJunyent, F.
dc.creatorFolch, J.
dc.creatorPelegri, C.
dc.creatorVilaplana, J.
dc.creatorAuladell, C.
dc.creatorBeas-Zárate, Carlos
dc.creatorPalls, M.
dc.creatorCamins, A.
dc.creatorVerdaguer, E.
dc.date.accessioned2015-11-19T18:57:38Z
dc.date.accessioned2022-11-02T14:26:12Z
dc.date.available2015-11-19T18:57:38Z
dc.date.available2022-11-02T14:26:12Z
dc.date.created2015-11-19T18:57:38Z
dc.date.issued2011
dc.identifierhttp://hdl.handle.net/20.500.12104/71027
dc.identifier10.1016/j.neuint.2011.03.027
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-79960373301&partnerID=40&md5=1ad81781a84806f978e9413cfa40439d
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4998050
dc.description.abstractIn the present study we focused in the PI3K/Akt pathway which plays a key role in neuronal survival. Here we show that inhibition of PI3K/Akt by means of LY294002 induces apoptosis via a caspase-dependent and calpain-independent pathway in cerebellar granule neurons (CGNs). This finding was confirmed using zVAD-fmk, a widely caspase inhibitor that prevents apoptosis. For this purpose, we compared two models of apoptosis in CGNs, namely inhibition of PI3K/Akt, and serum potassium deprivation (S/K deprivation). In contrast to the S/K deprivation model, caspase-3 was not activated when PI3K is inhibited. Likewise, CDK5 activation was not involved in this apoptotic process, because calpain activation is responsible for the formation of CDK5/p25 neurotoxic form. However, S/K deprivation activated calpain, as it is shown by α-spectrin breakdown, and favoured the formation of CDK5/p25. Moreover, although PI3K/Akt inhibition enhanced pRbser780 phosphorylation, no increase in the expression of cell-cycle proteins, namely: cyclin D, cyclin E, CDK2 or CDK4, was detected. Furthermore, BrdU incorporation assay did not shown any increase in DNA synthesis. Likewise, PI3K/Akt inhibition increased GSK3β activity and c-Jun phosphorylation, which implicates these two pathways in this apoptotic route. Although previous reports suggest that apoptosis induced in CGNs by LY294002 and S/K deprivation causes PI3K inhibition and increases GSK3β activity and c-Jun phosphorylation activation, our results demonstrate substantial differences between them and point to a key role of GSK3β in the apoptosis induced in CGNs in the two models tested. © 2011 Elsevier B.V. All rights reserved.
dc.relationNeurochemistry International
dc.relation59
dc.relation2
dc.relation159
dc.relation167
dc.relationScopus
dc.relationWOS
dc.titleStudy of the pathways involved in apoptosis induced by PI3K inhibition in cerebellar granule neurons
dc.typeArticle


Este ítem pertenece a la siguiente institución